ArticleJournal of managed care & specialty pharmacy2022

The potential long-term comparative effectiveness of larotrectinib vs standard of care for treatment of metastatic TRK fusion thyroid cancer, colorectal cancer, and soft tissue sarcoma.

Kangho Suh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.